Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis

2019
journal article
article
cris.lastimport.wos2024-04-09T22:26:12Z
dc.affiliationWydział Lekarski : Klinika Neurologiipl
dc.cm.date2020-12-02
dc.cm.id96590
dc.contributor.authorHoward, James F.pl
dc.contributor.authorBril, Verapl
dc.contributor.authorBurns, Ted M.pl
dc.contributor.authorMantegazza, Renatopl
dc.contributor.authorBilinska, Malgorzatapl
dc.contributor.authorSzczudlik, Andrzej - 133576 pl
dc.contributor.authorBeydoun, Saidpl
dc.contributor.authorRodriguez De Rivera Garrido, Francisco Javierpl
dc.contributor.authorPiehl, Fredrikpl
dc.contributor.authorRottoli, Mariarosapl
dc.contributor.authorVan Damme, Philippl
dc.contributor.authorVu, Tuanpl
dc.contributor.authorEvoli, Ameliapl
dc.contributor.authorFreimer, Miriampl
dc.contributor.authorMozaffar, Tahseenpl
dc.contributor.authorWard, E. Sallypl
dc.contributor.authorDreier, Torstenpl
dc.contributor.authorUlrichts, Peterpl
dc.contributor.authorVerschueren, Katrienpl
dc.contributor.authorGuglietta, Antoniopl
dc.contributor.authorde Haard, Hanspl
dc.contributor.authorLeupin, Nicolaspl
dc.contributor.authorVerschuuren, Jan J.G.M.pl
dc.date.accessioned2020-12-02T10:07:51Zpl
dc.date.available2020-12-02T10:07:51Zpl
dc.date.issued2019pl
dc.description.number23pl
dc.description.physicalE2661-E2673pl
dc.description.points140pl
dc.description.volume92pl
dc.identifier.doi10.1212/WNL.0000000000007600pl
dc.identifier.eissn1526-632Xpl
dc.identifier.issn0028-3878pl
dc.identifier.projectROD UJ / Opl
dc.identifier.urihttps://ruj.uj.edu.pl/xmlui/handle/item/256364
dc.languageengpl
dc.language.containerengpl
dc.rightsDodaję tylko opis bibliograficzny*
dc.rights.licencebez licencji
dc.subtypeArticlepl
dc.titleRandomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravispl
dc.title.journalNeurologypl
dc.typeJournalArticlepl
dspace.entity.typePublication
cris.lastimport.wos
2024-04-09T22:26:12Z
dc.affiliationpl
Wydział Lekarski : Klinika Neurologii
dc.cm.date
2020-12-02
dc.cm.id
96590
dc.contributor.authorpl
Howard, James F.
dc.contributor.authorpl
Bril, Vera
dc.contributor.authorpl
Burns, Ted M.
dc.contributor.authorpl
Mantegazza, Renato
dc.contributor.authorpl
Bilinska, Malgorzata
dc.contributor.authorpl
Szczudlik, Andrzej - 133576
dc.contributor.authorpl
Beydoun, Said
dc.contributor.authorpl
Rodriguez De Rivera Garrido, Francisco Javier
dc.contributor.authorpl
Piehl, Fredrik
dc.contributor.authorpl
Rottoli, Mariarosa
dc.contributor.authorpl
Van Damme, Philip
dc.contributor.authorpl
Vu, Tuan
dc.contributor.authorpl
Evoli, Amelia
dc.contributor.authorpl
Freimer, Miriam
dc.contributor.authorpl
Mozaffar, Tahseen
dc.contributor.authorpl
Ward, E. Sally
dc.contributor.authorpl
Dreier, Torsten
dc.contributor.authorpl
Ulrichts, Peter
dc.contributor.authorpl
Verschueren, Katrien
dc.contributor.authorpl
Guglietta, Antonio
dc.contributor.authorpl
de Haard, Hans
dc.contributor.authorpl
Leupin, Nicolas
dc.contributor.authorpl
Verschuuren, Jan J.G.M.
dc.date.accessionedpl
2020-12-02T10:07:51Z
dc.date.availablepl
2020-12-02T10:07:51Z
dc.date.issuedpl
2019
dc.description.numberpl
23
dc.description.physicalpl
E2661-E2673
dc.description.pointspl
140
dc.description.volumepl
92
dc.identifier.doipl
10.1212/WNL.0000000000007600
dc.identifier.eissnpl
1526-632X
dc.identifier.issnpl
0028-3878
dc.identifier.projectpl
ROD UJ / O
dc.identifier.uri
https://ruj.uj.edu.pl/xmlui/handle/item/256364
dc.languagepl
eng
dc.language.containerpl
eng
dc.rights*
Dodaję tylko opis bibliograficzny
dc.rights.licence
bez licencji
dc.subtypepl
Article
dc.titlepl
Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
dc.title.journalpl
Neurology
dc.typepl
JournalArticle
dspace.entity.type
Publication

* The migration of download and view statistics prior to the date of April 8, 2024 is in progress.

Views
0
Views per month

No access

No Thumbnail Available